Novel Applications of E3 Ubiquitin Ligase Technology

Publication ID: 24-11857519_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Novel Applications of E3 Ubiquitin Ligase Technology,” Published Technical Disclosure No. 24-11857519_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857519_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,519.

Summary of the Inventive Concept

This inventive concept expands the scope of E3 ubiquitin ligase technology beyond its original application in targeted protein degradation, exploring its potential in environmental monitoring, food safety, counterfeit detection, industrial process optimization, and bioterrorism agent detection.

Background and Problem Solved

The original patent disclosed compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide. However, the limitations of this technology lie in its narrow focus on a specific biological target. The new inventive concept addresses this limitation by applying the core E3 ubiquitin ligase technology to entirely new industries and problems, thereby increasing its versatility and impact.

Detailed Description of the Inventive Concept

The new inventive concept involves the design and implementation of novel systems and methods that utilize E3 ubiquitin ligase proteins to detect and analyze specific target proteins indicative of various phenomena, such as water pollution, food spoilage, counterfeit goods, process efficiency, and bioterrorism agents. These systems comprise sensor modules, processing modules, and verification modules that work in tandem to provide accurate and reliable readings. The E3 ubiquitin ligase proteins are engineered to ubiquitinate the target proteins, which are then detected and analyzed to provide meaningful insights.

Novelty and Inventive Step

The new inventive concept's novelty lies in its application of E3 ubiquitin ligase technology to non-biological targets and industries, as well as its innovative system designs and methods. The inventive step is the recognition of the potential of E3 ubiquitin ligase proteins to ubiquitinate target proteins beyond biological contexts, enabling the development of novel detection and analysis systems.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of ubiquitin ligases, varying sensor module configurations, or the integration of machine learning algorithms to enhance data analysis. Variations could also involve adapting the technology for use in other industries, such as healthcare or agriculture.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in various industries, including environmental monitoring, food safety, luxury goods authentication, industrial process optimization, and bioterrorism detection. The market for these applications is substantial, with growing demands for efficient and accurate detection and analysis systems.

CPC Classifications

SectionClassGroup
A A61 A61K31/166
A A61 A61K31/351
A A61 A61K31/405
A A61 A61K38/45
A A61 A61K47/545
A A61 A61K47/55
A A61 A61K47/555
A A61 A61P35/00
C C07 C07D401/14
C C07 C07D405/12
C C07 C07D405/14
C C07 C07D409/14
C C07 C07D417/14
C C07 C07D471/04
C C12 C12N9/1007
C C12 C12Y201/01043

Original Patent Information

Patent NumberUS 11,857,519
TitleCompounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
Assignee(s)Arvinas Operations, Inc.